Our scientific focus is the development of mass spectrometry based methods for biomarker research, particularly with regard to early disease diagnosis. Especially the questions: How aberrantly does the body work under pathological changes? and Which mechanisms lead to the pathological changes? are processed by us. Thereby, we are following the strategy to investigate alteration on protein level in association with the metabolite level. By applying comparative proteomic studies disease specific differential proteins are identified.